Global Botulinum Toxin Market 2022-2028

September 2022 | 80 pages | ID: G62C6AF7EDB7EN
Gen Consulting Company

Abstracts

The global botulinum toxin market is likely to register a CAGR of over 7.8% with an incremental growth of USD 3 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global botulinum toxin market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the botulinum toxin industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for botulinum toxin can be segmented by product: type A botulinum toxin, type B botulinum toxin. Botulinum toxin market is further segmented by application: aesthetic, medical. Based on end user, the botulinum toxin market is segmented into: hospitals, specialty and dermatology clinics, others. On the basis of region, the botulinum toxin market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:

• type A botulinum toxin
• type B botulinum toxin

By application:

• aesthetic
• medical

By end user:

• hospitals
• specialty and dermatology clinics
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The aesthetic application market is further segmented into forehead lines, glabellar lines, lateral canthal lines (crow's feet), others. Furthermore, the medical application market has been categorized into chronic migraine, hyperhidrosis, muscle spasm, over reactive bladder, others.

The report also provides analysis of the key companies of the industry and their detailed company profiles including AbbVie Inc. (Allergan plc), Daewoong Pharmaceutical Co., Ltd., Evolus Inc., Galderma S.A., HUGEL Inc., Ipsen S.A., Lanzhou Institute of Biological Products Co., Ltd., Medy-Tox Inc., Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., US WorldMeds LLC, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global botulinum toxin market.
• To classify and forecast the global botulinum toxin market based on product, application, end user, region.
• To identify drivers and challenges for the global botulinum toxin market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global botulinum toxin market.
• To identify and analyze the profile of leading players operating in the global botulinum toxin market.

Why Choose This Report

• Gain a reliable outlook of the global botulinum toxin market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Type A botulinum toxin
Type B botulinum toxin

PART 6. MARKET BREAKDOWN BY APPLICATION

Aesthetic
Medical

PART 7. MARKET BREAKDOWN BY END USER

Hospitals
Specialty and dermatology clinics
Others

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 9. KEY COMPANIES

AbbVie Inc. (Allergan plc)
Daewoong Pharmaceutical Co., Ltd.
Evolus Inc.
Galderma S.A.
HUGEL Inc.
Ipsen S.A.
Lanzhou Institute of Biological Products Co., Ltd.
Medy-Tox Inc.
Merz Pharma GmbH & Co. KGaA
Revance Therapeutics Inc.
US WorldMeds LLC
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER